Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL
Clinical trial NCT02546739 · UNKNOWN
Trial details
- NCT number
- NCT02546739
- Sponsor
- Beijing Doing Biomedical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2022-03-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.